Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

17.12.13	Pfizer Resolves Patent Litigation Against Teva - Quick Facts (RTTNews)
17.12.13	Pfizer Makes Several Senior Executive Appointments - Quick Facts (RTTNews)
16.12.13	Siemens Healthcare Reaches Master Deal With Pfizer For Companion Diagnostics (RTTNews)
12.12.13	Lpath Withdraws From Pfizer' Process To Assign ISONEP Rights (RTTNews)
02.12.13	Pfizer's Unit Buys Polocard, A Low-dose Aspirin - Quick Facts (RTTNews)
02.12.13	Pfizer Acquires Polocard, Poland’s Leading Over-The-Counter Heart Attack Prevention Brand (Businesswire)
22.11.13	ViiV Healthcare: Tivicay Gets Positive CHMP Opinion In Europe To Treat HIV (RTTNews)
21.11.13	Pfizer, GSK To Collaborate For Phase I/II Study With Palbociclib & Trametinib (RTTNews)
18.11.13	Pfizer Receives FDA Approval For XELJANZ - Quick Facts (RTTNews)
08.11.13	Pfizer: Rapamune Phase 3B/4 Study Fails To Meet Primary Endpoint - Quick Facts (RTTNews)
05.11.13	Pfizer Says FDA Okays Prior Approval Supplement For EMBEDA ER Capsules CII (RTTNews)
29.10.13	Pfizer Q3 Profit Falls, Cancer Drugs Post Double-digit Revenue Growth (RTTNews)
29.10.13	Pre-market Movers For Oct 29 (AAPL, NOK, PFE, VOLC, STX) (RTTNews)
29.10.13	Pfizer Q3 Profit Down; Updates FY13 Outlook - Quick Facts (RTTNews)
29.10.13	Earnings Watch For October 29 (PFE, BIDU, DWA, LNKD, EA) (RTTNews)
23.10.13	EPZM, MDVN On Watch, MYGN In Legal Spat With BRLI, ONVO's 3D Story Gets Better (RTTNews)
22.10.13	ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV (PR Newswire)
22.10.13	DURECT Says Pfizer Will Continue Development Program For REMOXY (RTTNews)
22.10.13	Pfizer Proceeding with REMOXY® Development (PR Newswire)
22.10.13	Stock Price Movements, Clinical Study Results, and New Appointments - Research Report on Pfizer, Gilead Sciences, Amgen, Celgene, and Insys Therapeutics (PR Newswire)
21.10.13	Innovative Biotechs Making Strides In Healthcare Sector: Alliqua, MiMedx, Organovo, Anacor Pharmaceuticals, Pfizer (PR Newswire)
18.10.13	Pfizer Reports Results From Two Lyrica Capsules CV Phase 3b Studies (RTTNews)
17.10.13	Pfizer Gets European Approval For Label Update Regarding Use Of Prevenar 13 (RTTNews)
14.10.13	Clinical Trial Results, Conference Calls, and Acquisitions - Research Report on Pfizer, UnitedHealth, Actavis, Bristol-Myers Squibb, and Quest Diagnostics (PR Newswire)
09.10.13	Pfizer Reports Top-line Results From Tofacitinib Phase 3 Trials - Quick Facts (RTTNews)
09.10.13	FDA Approvals, Completed Tender Offers, Hospital Ratings, Trial Study Results, and Stock Price Movements - Research Report on Pfizer, Amgen, Cigna, Hologic, and Insys Therapeutics (PR Newswire)
07.10.13	Critical Alerts For Pfizer, Universal Display, Royal Gold, Las Vegas Sands, and NVIDIA Released By InvestorsObserver (PR Newswire)
04.10.13	Under AAAResearchReports.com Microscope: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. (PR Newswire)
03.10.13	Pfizer Announces FDA Approval For DUAVEE Therapy - Quick Facts (RTTNews)
02.10.13	Regulatory Approval, New Appointments, Stock Price Movements, and Other Announcements - Research Report on Pfizer, Warner Chilcott, Rockwell Medical, InterMune, and Ligand (PR Newswire)
01.10.13	Pharmaceutical Companies Announce Trial Results, and Achieve New Contracts, Regulatory Approvals, and Positive Opinion - Research Report on Eli Lilly, Pfizer, Novartis, Sanofi, and AstraZeneca (PR Newswire)
30.09.13	Presentation, Licensing Agreement, Trial Milestone, Positive Opinion, and Trade Name Acceptance - Research Report on Pfizer, Allergan, Novartis, AstraZeneca, and Rockwell Medical (PR Newswire)
30.09.13	Bayer Appoints Olivier Brandicourt As CEO Of HealthCare Unit - Quick Facts (RTTNews)
24.09.13	Stock Movements, Quarterly Dividends and Product Recall News - Research Report on Pfizer, Johnson & Johnson, Bristol-Myers, Merck, and Abbvie (PR Newswire)
20.09.13	Issuer Ratings, Recognitions, Positive Clinical Results, and Quarterly Dividends - Research Report on Pfizer, UnitedHealth, Merck, Gilead, and Bristol-Myers (PR Newswire)
19.09.13	Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine (PR Newswire)
18.09.13	Clinical Trial Results, Licensing Agreements, Breakthrough Research and Development Programs - Research Report on Pfizer, Merck, Rockwell Medical, GlaxoSmithKline, and Novartis (PR Newswire)
13.09.13	GlycoMimetics' GMI-1070 Granted Orphan Drug Designation In EU - Quick Facts (RTTNews)
13.09.13	ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1 (PR Newswire)
09.09.13	Event, FDA Approval, Positive Results, Partnership, and Marketing Authorization - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Lilly, and GSK (PR Newswire)
06.09.13	Critical Alerts For FedEx, AmerisourceBergen, Yelp, Pfizer, and Monsanto Released By InvestorsObserver (PR Newswire)
03.09.13	BMY, Pfizer Records Consistent Results In Sub-analysis Of Eliquis Vs. Warfarin (RTTNews)
31.08.13	Bristol-Myers,Pfizer Report Results Of Post-hoc Subanalysis From ARISTOTLE Trial (RTTNews)
29.08.13	Early Briefing and Review: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. (PR Newswire)
29.08.13	Pfizer Closes Pneumococcal Pneumonia Case Accrual For CAPiTA - Quick Facts (RTTNews)
19.08.13	MNKD To Get Financing, PTIE, DRRX Vault, BMRN On Watch (RTTNews)
13.08.13	UPDATE: Multimedia Assets Now Available: ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1 (PR Newswire)
13.08.13	ViiV Healthcare Says FDA Approves HIV Drug Tivicay (RTTNews)
13.08.13	ViiV Healthcare Announces FDA Approves Tivicay For HIV-1 Treatment - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	255.50	0.75 %	K V
Nestle	74.88	0.62 %	K V
CieFinRichemont	137.90	0.40 %	K V
Swiss Life Hldg	699.60	0.32 %	K V
Swisscom	504.50	0.30 %	K V
Sika	215.80	-0.37 %	K V
Givaudan	3’966.00	-0.40 %	K V
Lonza Grp	535.80	-0.41 %	K V
Geberit	514.60	-0.46 %	K V
ABB	49.07	-0.95 %	K V

mehr

30.12.24		Montagshandel in New York: Dow Jones fällt schlussendlich zurück
30.12.24		Dow Jones aktuell: Dow Jones schwächelt am Montagnachmittag
30.12.24		XETRA-Handel TecDAX präsentiert sich zum Ende des Montagshandels schwächer
30.12.24		Börse Zürich in Grün: SMI steigt schlussendlich
30.12.24		STOXX-Handel Euro STOXX 50 gibt zum Ende des Montagshandels nach
30.12.24		FTSE 100-Handel aktuell: FTSE 100 fällt zum Handelsende
30.12.24		Aufschläge in Zürich: SPI beendet den Handel im Plus
30.12.24		MDAX aktuell: MDAX zum Handelsende im Minus

30.12.24

Montagshandel in New York: Dow Jones fällt schlussendlich zurück

30.12.24

Dow Jones aktuell: Dow Jones schwächelt am Montagnachmittag

30.12.24

XETRA-Handel TecDAX präsentiert sich zum Ende des Montagshandels schwächer

30.12.24

Börse Zürich in Grün: SMI steigt schlussendlich

30.12.24

STOXX-Handel Euro STOXX 50 gibt zum Ende des Montagshandels nach

30.12.24

FTSE 100-Handel aktuell: FTSE 100 fällt zum Handelsende